Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
Neo-Concept International Group Holdings Limited Ordinary Shares

NCI

Neo-Concept International Group Holdings Limited Ordinary Shares

Neo-Concept International Group Holdings Limited Ordinary Shares historical holders

total: 2

Pzena Investment Management Neo-Concept International Group Holdings Limited Ordinary Shares transactions over time

Total transactions:
6
New positions:
1
Sold out:
1
Added:
1
Reduced:
3
Held since:
2018 Q2
Held for:
5 quarters
Latest activity:
2019 Q3
Richard Pzena has been an institutional investor in Neo-Concept International Group Holdings Limited Ordinary Shares (NCI) since 2018 Q2. According to 2026 Q1 report, Richard Pzena doesn't hold any shares. The fund/company first acquired NCI in 2018 Q2, initially purchasing about 1.71M shares. Since the initial investment, Pzena Investment Management has made 5 more transactions in this position.

When did Richard Pzena exit their NCI position?

Richard Pzena no longer holds Neo-Concept International Group Holdings Limited Ordinary Shares (NCI). They sold off their entire position in 2019 Q3, closing out an investment that began in 2018 Q2.

When did Richard Pzena first invest in NCI?

Richard Pzena first invested in Neo-Concept International Group Holdings Limited Ordinary Shares (NCI) in 2018 Q2 at the reported quarter-end price of $22.14 per share, acquiring 1,706,924 shares in their initial purchase.

What is Richard Pzena's average cost basis for NCI?

Based on historical transaction data, Richard Pzena's estimated cost basis for Neo-Concept International Group Holdings Limited Ordinary Shares (NCI) is approximately $22.14 per share. This represents their average reported price* across all buy transactions.

Estimated cost basis*

Weighted AVG buy price:
$22.14
Weighted AVG sell price:
$22.17

NCI transactions history by Pzena Investment Management

6 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2019 Q3
0.00%
$23.19
-100% (-549,721)
2019 Q2
0.07%
$23.19
+0.98% (+5,309)
2019 Q1
0.06%
$19.47
-52.24% (-595,434)
2018 Q4
0.16%
$24.05
-32.75% (-555,215)
2018 Q3
0.19%
$23.06
-0.69% (-11,863)
2018 Q2
0.19%
$22.14
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.